U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

There is one exact (name or code) match for isoflurophate

 

ISOFLUROPHATE

MORE DETAILS

  12UHW9R67N

Status:
US Previously Marketed
Source:
Floropryl by Merck
(1949)
Source URL:
DeHaen 1940-1975 NMEs
First approved in 1949
Source:
Floropryl by Merck
Source URL:
DeHaen 1940-1975 NMEs
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Acetylcholinesterase
209
Conditions:
Chronic glaucoma
1
Isofluorophate (diisopropyl fluorophosphate) is an irreversile acetylcholinesterase inhibitor. It was used in ophthalmology as a miotic agent in treatment of chronic glaucoma.

ISOFLUROPHATE

MORE DETAILS

  12UHW9R67N

Status:
US Previously Marketed
Source:
Floropryl by Merck
(1949)
Source URL:
DeHaen 1940-1975 NMEs
First approved in 1949
Source:
Floropryl by Merck
Source URL:
DeHaen 1940-1975 NMEs
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Acetylcholinesterase
209
Conditions:
Chronic glaucoma
1
Isofluorophate (diisopropyl fluorophosphate) is an irreversile acetylcholinesterase inhibitor. It was used in ophthalmology as a miotic agent in treatment of chronic glaucoma.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966